Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

SciClone Pharmaceuticals Company Profile (NASDAQ:SCLN)

Consensus Ratings for SciClone Pharmaceuticals (NASDAQ:SCLN) (?)
Ratings Breakdown: 2 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $9.00 (4.66% downside)

Analysts' Ratings History for SciClone Pharmaceuticals (NASDAQ:SCLN)
Show:
DateFirmActionRatingPrice TargetActions
5/6/2015ZacksDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/6/2015AegisReiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/19/2014AegisSet Price TargetBuy$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/14/2014BWS FinancialDowngradeBuy -> Hold$8.25 -> $8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/29/2014AegisReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/12/2013AegisLower Price TargetBuy$9.00 -> $8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/25/2013AegisReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/9/2013TheStreetDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/16/2013AegisUpgradeHold -> Buy$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/26/2013 forward)